1. Home
  2. IMNM vs LEGH Comparison

IMNM vs LEGH Comparison

Compare IMNM & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • LEGH
  • Stock Information
  • Founded
  • IMNM 2006
  • LEGH 2005
  • Country
  • IMNM United States
  • LEGH United States
  • Employees
  • IMNM N/A
  • LEGH N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • LEGH Homebuilding
  • Sector
  • IMNM Health Care
  • LEGH Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • LEGH Nasdaq
  • Market Cap
  • IMNM 747.7M
  • LEGH 682.3M
  • IPO Year
  • IMNM 2020
  • LEGH 2018
  • Fundamental
  • Price
  • IMNM $9.91
  • LEGH $25.89
  • Analyst Decision
  • IMNM Strong Buy
  • LEGH Buy
  • Analyst Count
  • IMNM 5
  • LEGH 2
  • Target Price
  • IMNM $28.60
  • LEGH $29.00
  • AVG Volume (30 Days)
  • IMNM 695.8K
  • LEGH 46.2K
  • Earning Date
  • IMNM 11-13-2024
  • LEGH 11-12-2024
  • Dividend Yield
  • IMNM N/A
  • LEGH N/A
  • EPS Growth
  • IMNM N/A
  • LEGH N/A
  • EPS
  • IMNM N/A
  • LEGH 2.18
  • Revenue
  • IMNM $10,129,000.00
  • LEGH $163,718,000.00
  • Revenue This Year
  • IMNM N/A
  • LEGH N/A
  • Revenue Next Year
  • IMNM N/A
  • LEGH $7.70
  • P/E Ratio
  • IMNM N/A
  • LEGH $11.89
  • Revenue Growth
  • IMNM N/A
  • LEGH N/A
  • 52 Week Low
  • IMNM $6.93
  • LEGH $19.42
  • 52 Week High
  • IMNM $30.96
  • LEGH $29.31
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 30.69
  • LEGH 45.79
  • Support Level
  • IMNM $12.46
  • LEGH $26.96
  • Resistance Level
  • IMNM $13.52
  • LEGH $27.35
  • Average True Range (ATR)
  • IMNM 0.85
  • LEGH 0.77
  • MACD
  • IMNM -0.15
  • LEGH 0.02
  • Stochastic Oscillator
  • IMNM 6.71
  • LEGH 36.64

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to customers to facilitate the sale of homes.

Share on Social Networks: